Cargando…
Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546712/ https://www.ncbi.nlm.nih.gov/pubmed/33045189 http://dx.doi.org/10.1016/S0140-6736(20)32132-2 |
| _version_ | 1783592277146337280 |
|---|---|
| author | Carlet, Jean Payen, Didier Opal, Steven M |
| author_facet | Carlet, Jean Payen, Didier Opal, Steven M |
| author_sort | Carlet, Jean |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7546712 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75467122020-10-13 Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19 Carlet, Jean Payen, Didier Opal, Steven M Lancet Correspondence Elsevier Ltd. 2020 2020-10-09 /pmc/articles/PMC7546712/ /pubmed/33045189 http://dx.doi.org/10.1016/S0140-6736(20)32132-2 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Carlet, Jean Payen, Didier Opal, Steven M Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19 |
| title | Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19 |
| title_full | Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19 |
| title_fullStr | Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19 |
| title_full_unstemmed | Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19 |
| title_short | Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19 |
| title_sort | steroids for sepsis and ards: this eternal controversy remains with covid-19 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546712/ https://www.ncbi.nlm.nih.gov/pubmed/33045189 http://dx.doi.org/10.1016/S0140-6736(20)32132-2 |
| work_keys_str_mv | AT carletjean steroidsforsepsisandardsthiseternalcontroversyremainswithcovid19 AT payendidier steroidsforsepsisandardsthiseternalcontroversyremainswithcovid19 AT opalstevenm steroidsforsepsisandardsthiseternalcontroversyremainswithcovid19 |